TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9315423

Group type: EXPERIMENTAL
Intervention: Tracking strategies (telephone interviews, calling parents, reviewing charts, sending surveys, offering incentives)
Number of subjects: 16915

Group type: EXPERIMENTAL
Intervention: Baseline tobacco and alcohol use
Number of subjects: 16915

Group type: EXPERIMENTAL
Intervention: Number of procedures used to track participants
Number of subjects: 16915
Study: 8253935

Group type: EXPERIMENTAL
Intervention: Co-culture with granulosa cells
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 2882772

Group type: EXPERIMENTAL
Intervention: Intravenous celiprolol (8 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Buccal nitroglycerine (10 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of celiprolol and nitroglycerine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Celiprolol during exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nitrate therapy during exercise
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination therapy during exercise
Number of subjects: 24
Study: 31881928

Group type: EXPERIMENTAL
Intervention: HPV self-collection intervention (mailed kits for self-collection of samples for HPV testing)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Control (scheduling assistance alone)
Number of subjects: 510
Study: 29889055

Group type: EXPERIMENTAL
Intervention: Complex training (combination of plyometric and weight training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plyometric training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Weight training
Number of subjects: 30
Study: 26810596

Group type: EXPERIMENTAL
Intervention: Nonsustained ventricular tachycardia (NSVT) detected within the first 30 days after randomization
Number of subjects: 2866

Group type: EXPERIMENTAL
Intervention: Nonsustained ventricular tachycardia (NSVT) detected after 30 days
Number of subjects: 2866

Group type: EXPERIMENTAL
Intervention: NSVT detected during the convalescent phase (n=428/1991; 21.5%)
Number of subjects: 2866
Study: 24446820

Group type: EXPERIMENTAL
Intervention: Arizona Attorney General's Social Networking Safety Promotion and Cyberbullying Prevention presentation
Number of subjects: 425
Study: 22796548

Group type: EXPERIMENTAL
Intervention: ICG:HSA
Number of subjects: 18

Group type: COMPARATOR
Intervention: ICG alone
Number of subjects: 18
Study: 20232240

Group type: EXPERIMENTAL
Intervention: Manualized social intervention including instruction and therapeutic activities targeting social skills, face-emotion recognition, interest expansion, and interpretation of non-literal language.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list condition (control group).
Number of subjects: 0
Study: 17492431

Group type: EXPERIMENTAL
Intervention: Assist-control ventilation (ACV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low pressure support ventilation (low PSV)
Number of subjects: 20
Study: 15447920

Group type: EXPERIMENTAL
Intervention: Bed rest (SED group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bed rest with supine treadmill exercise (EX group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chamber study (EX group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chamber study (SED group)
Number of subjects: 16
Study: 11273843

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) diet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-Fat (HF) diet
Number of subjects: 35
Study: 9602984

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily for 3 days)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Co-amoxiclav (500 mg three times daily for 10 days)
Number of subjects: 254
Study: 8011967

Group type: EXPERIMENTAL
Intervention: Oral prednisone dose of 0.8 mg kg‐1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous prednisolone dose of 0.66 mg kg‐1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both prednisone and prednisolone
Number of subjects: 12
Study: 2718915

Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise-induced changes in fat oxidation
Number of subjects: 0
Study: 31446625

Group type: EXPERIMENTAL
Intervention: CAF + CTG
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CAF + ECTG
Number of subjects: 17

Group type: COMPARATOR
Intervention: CAF-alone (adjacent treated sites)
Number of subjects: 17
Study: 26704762

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no omega-3 supplementation)
Number of subjects: 120
Study: 25346460

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5-0.7 μg/kg/h)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Propofol (6-8 mg/kg/h)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both Dexmedetomidine and Propofol
Number of subjects: 57
Study: 23272985

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment strategy (including pharmacological and non-pharmacological therapy)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Usual care (CAU)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Depression treatment (received by 168 patients)
Number of subjects: 331
Study: 21489819

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation program for 23 ± 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical standard therapy (physiotherapy)
Number of subjects: 60
Study: 19649553

Group type: EXPERIMENTAL
Intervention: First-person shooter game (Half Life)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cognitive demands video game (Chessmaster)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No video game training (Control group)
Number of subjects: 30
Study: 16420547

Group type: COMPARATOR
Intervention: Standard treatment (mostly semisynthetic penicillin)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Levofloxacin combined with standard treatment
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Rifampicin (when deep infection suspected)
Number of subjects: 381
Study: 15572743

Group type: EXPERIMENTAL
Intervention: Psycho-educational workshops (cognitive-behavioural approach)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 120
Study: 11282762

Group type: EXPERIMENTAL
Intervention: 60% O(2) during exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Room air (RA) during exercise
Number of subjects: 11
Study: 9227199

Group type: EXPERIMENTAL
Intervention: 100% oxygen + 0% nitrogen
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10% oxygen + 90% nitrogen
Number of subjects: 16
Study: 8214916

Group type: EXPERIMENTAL
Intervention: Amiloride inhalation therapy (5 x 10(‐3) M amiloride in one‐third normal saline four times a day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (one‐third normal saline)
Number of subjects: 6
Study: 3609190

Group type: EXPERIMENTAL
Intervention: Higher nicotine cigarette (1.4 mg nicotine, 10 mg tar)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lower tar cigarette (10 mg tar, 1.4 mg nicotine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cigarettes with the same tar level
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cigarettes with the same nicotine level
Number of subjects: 10
Study: 31811577

Group type: EXPERIMENTAL
Intervention: Conduct disorder
Number of subjects: 30532
Study: 30772671

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 6 months
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Brachytherapy plus external beam radiation
Number of subjects: 116

Group type: COMPARATOR
Intervention: External beam radiation alone
Number of subjects: 116

Group type: COMPARATOR
Intervention: No ADT
Number of subjects: 116
Study: 28650326

Group type: EXPERIMENTAL
Intervention: CofNovex plus (EMA) syrup
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 26330422

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg every 2 weeks (Q2W), increased to 150 mg Q2W at Week 12 if LDL-C ≥1.8 mmol/L
Number of subjects: 735

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 735
Study: 23793983

Group type: EXPERIMENTAL
Intervention: Chemotherapy-induced amenorrhea (CIA) group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Post-menopausal BC patients undergoing chemotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls (pre- and post-menopausal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CIA group
Number of subjects: 30
Study: 21666789

Group type: EXPERIMENTAL
Intervention: Multi-nutrient supplementation
Number of subjects: 612

Group type: COMPARATOR
Intervention: No multi-nutrient supplementation
Number of subjects: 612
Study: 18977585

Group type: EXPERIMENTAL
Intervention: 100U Botulinum toxin (Dysport)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 140U Botulinum toxin (Dysport)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16505650

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day, group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 40
Study: 12926583

Group type: EXPERIMENTAL
Intervention: Treatment arm (T)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator arm (C)
Number of subjects: 0
Study: 10856536

Group type: COMPARATOR
Intervention: 40 mg fluvastatin alone
Number of subjects: 333

Group type: COMPARATOR
Intervention: 400 mg bezafibrate alone
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: 20 mg fluvastatin + 400 mg bezafibrate
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: 40 mg fluvastatin + 400 mg bezafibrate
Number of subjects: 333
Study: 9200048

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude cervical manipulation twice a week for 3 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low-level laser and deep friction massage twice a week for 3 weeks
Number of subjects: 53
Study: 7693533

Group type: EXPERIMENTAL
Intervention: Acid-protected porcine pancreatic extracts
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 3544353

Group type: EXPERIMENTAL
Intervention: Thymomodulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31987653

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 116

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Adjunctive phenobarbital
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Maternal psychological distress
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Infant medical problems
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Continued maternal substance use
Number of subjects: 116
Study: 30445988

Group type: EXPERIMENTAL
Intervention: High-protein diet + beta-cryptoxanthin (HPD+beta-CX)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Normal protein diet + beta-cryptoxanthin (NPD+beta-CX)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: High-protein diet + placebo (HPD+placebo)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Normal protein diet + placebo (NPD+placebo)
Number of subjects: 92
Study: 26456063

Group type: EXPERIMENTAL
Intervention: Timed Up and Go Test (TUGT)
Number of subjects: 278
Study: 24783914

Group type: EXPERIMENTAL
Intervention: Rituximab (1 course consisting of 2 infusions of 1,000 mg each) with background Methotrexate
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg twice weekly) with background Methotrexate
Number of subjects: 33
Study: 21083736

Group type: EXPERIMENTAL
Intervention: Fittydent(®)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protefix(®)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Seabond(®)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no adhesive)
Number of subjects: 30
Study: 20367669

Group type: EXPERIMENTAL
Intervention: APS 5% lotion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 50
Study: 18588701

Group type: EXPERIMENTAL
Intervention: Improvisational music therapy (biweekly sessions for 3 months)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 85
Study: 15818486

Group type: EXPERIMENTAL
Intervention: Innovative treatment (directly from step I to step III of the WHO analgesic ladder)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional three-step strategy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Innovative treatment
Number of subjects: 54
Study: 12625130

Group type: EXPERIMENTAL
Intervention: Insecticide-treated mosquito nets (ITNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ITNs)
Number of subjects: 0
Study: 12014724

Group type: EXPERIMENTAL
Intervention: 4 mg/day tegaserod
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 12 mg/day tegaserod
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Tegaserod pooled data
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Tegaserod (4 mg/day and 12 mg/day)
Number of subjects: 86
Study: 9599499

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for six weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation)
Number of subjects: 45
Study: 8025768

Group type: EXPERIMENTAL
Intervention: UK,74505 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: UK,74505 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study: 2663343

Group type: EXPERIMENTAL
Intervention: 7‐mono‐hydroxyethylrutoside
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 7‐mono‐hydroxyethylrutoside and acetylsalicylic acid combination
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 31623762

Group type: EXPERIMENTAL
Intervention: Alarms ON
Number of subjects: 907

Group type: COMPARATOR
Intervention: Alarms OFF
Number of subjects: 907
Study: 28658484

Group type: EXPERIMENTAL
Intervention: Polysyllable Preschool Test
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Print knowledge tasks
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Low polysyllable accuracy and poor phonological processing
Number of subjects: 93
Study: 25074354

Group type: EXPERIMENTAL
Intervention: Adaptive conjoint analysis (ACA) tool
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual counseling
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Adaptive conjoint analysis (ACA) tool (in subgroup analysis)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual counseling (in subgroup analysis)
Number of subjects: 374
Study: 23313654

Group type: EXPERIMENTAL
Intervention: Tdap-IPV and inactivated influenza vaccine administered concomitantly (Group 1)
Number of subjects: 954

Group type: COMPARATOR
Intervention: Inactivated influenza vaccine then Tdap-IPV 28‐35 days later (Group 2)
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 954
Study: 20822814

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 30
Study: 18821365

Group type: EXPERIMENTAL
Intervention: SRT+EMDR
Number of subjects: 43

Group type: COMPARATOR
Intervention: SRT
Number of subjects: 43
Study: 16468062

Group type: EXPERIMENTAL
Intervention: Naloxone (NAL) 0.1 mg kg(‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal saline (SAL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Naloxone (NAL)
Number of subjects: 15
Study: 12827024

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without perindopril and candesartan)
Number of subjects: 0
Study: 10984015

Group type: EXPERIMENTAL
Intervention: Acetyl starch (ACS) 6%
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hydroxyethyl starch (HES) 6%
Number of subjects: 32
Study: 9373790

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemotherapy using implanted reservoirs (Epirubicin 40 mg/m2 every month)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional transcatheter arterial chemotherapy (Epirubicin 60 mg/m2 every 3 months)
Number of subjects: 20
Study: 1492848

Group type: EXPERIMENTAL
Intervention: Flupirtine maleate 50 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Flupirtine maleate 100 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Flupirtine maleate 200 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Flupirtine maleate 300 mg
Number of subjects: 4
Study: 28698230

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE) with methylene blue 0.1%
Number of subjects: 131

Group type: COMPARATOR
Intervention: Narrow band imaging (NBI)
Number of subjects: 131
Study: 26992106

Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg plus standard therapy
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 1125
Study: 23765238

Group type: EXPERIMENTAL
Intervention: Adjuvant gemcitabine chemotherapy (800 mg/m2 biweekly for major hepatectomy or 1000 mg/m2 in 3 weekly infusions with a 1-week pause for others)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Adjuvant gemcitabine chemotherapy
Number of subjects: 198
Study: 22836057

Group type: EXPERIMENTAL
Intervention: Standard dose radiation therapy (6.0 Gy in 6 fractions of 1.0 Gy twice weekly)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low dose radiation therapy (0.6 Gy in 6 fractions of 0.1 Gy twice weekly)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Reirradiation (standard dosage) offered to patients with insufficient pain relief after 3 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patients with favorable results after 3 months
Number of subjects: 62
Study: 19847404

Group type: EXPERIMENTAL
Intervention: Anterior-posterior mini-incision instrumentation (Group B)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Quadriceps sparing side‐cutting instrumentation (Group A)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (with computer-assistance)
Number of subjects: 108
Study: 17988236

Group type: EXPERIMENTAL
Intervention: Predocol 40 mg/day
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Predocol 60 mg/day
Number of subjects: 181

Group type: COMPARATOR
Intervention: Tapering prednisolone
Number of subjects: 181
Study: 15837945

Group type: EXPERIMENTAL
Intervention: Losartan treatment
Number of subjects: 9079

Group type: COMPARATOR
Intervention: Atenolol treatment
Number of subjects: 9079
Study: 12028242

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (37.5 to 225 mg/day)
Number of subjects: 1839

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1839

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER
Number of subjects: 1839
Study: 10628598

Group type: EXPERIMENTAL
Intervention: Protocol-directed sedation (n = 162)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Non-protocol-directed sedation (n = 159)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Protocol-directed sedation (n = 66)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Non-protocol-directed sedation (n = 66)
Number of subjects: 321
Study: 7746398

Group type: EXPERIMENTAL
Intervention: Detrimental drug group (n = 37)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Neutral drug group (n = 59)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Detrimental drug group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Neutral drug group
Number of subjects: 96
Study: 1786954

Group type: EXPERIMENTAL
Intervention: Superoxide dismutase (SOD)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 7138048

Group type: EXPERIMENTAL
Intervention: 0.1% anthralin combined with UV-B therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.01% anthralin combined with UV-B therapy
Number of subjects: 9
Study: 30302940

Group type: EXPERIMENTAL
Intervention: Pre-hospital administration of ticagrelor
Number of subjects: 1630

Group type: COMPARATOR
Intervention: In-hospital administration of ticagrelor
Number of subjects: 1630

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 1630
Study: 30029204

Group type: EXPERIMENTAL
Intervention: Interactive Metronome (IM) training, 35-40 min per session, twice a week for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interactive Metronome (IM) training
Number of subjects: 20
Study: 26865039

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Lower Extremity Training (LET)
Number of subjects: 456
Study: 24144243

Group type: EXPERIMENTAL
Intervention: Bright light and melatonin capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dim light and melatonin capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bright light and placebo capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dim light and placebo capsules
Number of subjects: 40
Study: 22128084

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 311
Study: 19463608

Group type: EXPERIMENTAL
Intervention: Preoperative statin treatment
Number of subjects: 2152

Group type: COMPARATOR
Intervention: No statin treatment (control)
Number of subjects: 2152
Study: 17660640

Group type: EXPERIMENTAL
Intervention: Oral chloral hydrate (40 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo session
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both drug regimens (chloral hydrate and diazepam)
Number of subjects: 20
Study: 15295362

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin monohydrate macrocrystals
Number of subjects: 449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study: 11598383

Group type: EXPERIMENTAL
Intervention: High insulin (15 mU/kg x min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low insulin (1.5 mU/kg x min)
Number of subjects: 0
Study: 9594683

Group type: EXPERIMENTAL
Intervention: Vitamin B6 supplementation with isoniazid therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo with isoniazid therapy
Number of subjects: 85
Study: 7988298

Group type: EXPERIMENTAL
Intervention: Insulin-glucose infusion
Number of subjects: 327

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 327
Study: 2660054

Group type: EXPERIMENTAL
Intervention: Topical steroid treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Natural allergen exposure
Number of subjects: 20